Detalles de la búsqueda
1.
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Br J Nutr
; 127(11): 1613-1620, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176541
2.
J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD.
Nutr Metab Cardiovasc Dis
; 32(5): 1259-1265, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260312
3.
FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease.
Br J Nutr
; 126(6): 813-824, 2021 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198849
4.
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.
J Gastroenterol Hepatol
; 36(10): 2925-2934, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031913
5.
Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD.
Nutr Metab Cardiovasc Dis
; 31(2): 552-560, 2021 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33250371
6.
Metabolic-associated fatty liver disease is associated with severity of COVID-19.
Liver Int
; 40(9): 2160-2163, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573883
7.
PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.
Liver Int
; 40(1): 107-119, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519069
8.
Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
J Gastroenterol Hepatol
; 35(10): 1804-1812, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246876
9.
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
J Gastroenterol Hepatol
; 35(6): 1057-1064, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31677195
10.
Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.
Nutr Metab Cardiovasc Dis
; 30(10): 1820-1825, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32636124
11.
C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
Acta Pharmacol Sin
; 40(11): 1457-1465, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31186533
12.
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.
J Hepatol
; 73(3): 719-721, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32348790
13.
Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case-control study.
Eur J Gastroenterol Hepatol
; 34(8): 838-843, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694803
14.
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis.
J Clin Transl Hepatol
; 10(2): 219-229, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35528982
15.
PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.
J Clin Transl Hepatol
; 10(3): 439-448, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836754
16.
Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.
Front Med (Lausanne)
; 9: 864570, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35433752
17.
Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients.
Clin Mol Hepatol
; 28(2): 183-195, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839623
18.
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.
Metabolism
; 128: 154958, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958817
19.
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis.
Clin Mol Hepatol
; 27(2): 329-345, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33465844
20.
Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.
Turk J Gastroenterol
; 32(9): 758-764, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34609305